Radiation field design and regional control in sentinel lymph node-positive breast cancer patients with omission of axillary dissection

Cancer

Volumn 118, Issue 8, 2012, Pages 1994-2003

  Setton, Jeremy ^a   Cody, Hiram ^a   Tan, Lee ^a   Morrow, Monica ^a   Hudis, Clifford ^a   Catalano, Jeffrey ^a   McCormick, Beryl ^a   Powell, Simon ^a   Ho, Alice ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

axillary lymph node dissection; breast cancer; radiotherapy; sentinel lymph node biopsy

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BODY POSITION; BREAST CANCER; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RADIATION FIELD; SENTINEL LYMPH NODE; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RECURRENCE; SENTINEL LYMPH NODE BIOPSY;

EID: 84859636357     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26504     Document Type: Article

References (40)

1. Bilimoria KY, Bentrem DJ, Hansen NM, et al. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol. 2009; 27: 2946-2953.
2. Yi M, Giordano SH, Meric-Bernstam F, et al. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database. Ann Surg Oncol. 2010; 17: 343-351.
3. Van Zee KJ, Manasseh DM, Bevilacqua JL, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2003; 10: 1140-1151.
4. Park J, Fey JV, Naik AM, et al. A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram. Ann Surg. 2007; 245: 462-468.
5. Yegiyants S, Romero LM, Haigh PI, et al. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node. Arch Surg. 2010; 145: 564-569.
6. Hwang RF, Gonzalez-Angulo AM, Yi M, et al. Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer. 2007; 110: 723-730.
7. Pejavar S, Wilson LD, Haffty BG,. Regional nodal recurrence in breast cancer patients treated with conservative surgery and radiation therapy (BCS+RT). Int J Radiat Oncol Biol Phys. 2006; 66: 1320-1327.
8. Jeruss JS, Winchester DJ, Sener SF, et al. Axillary recurrence after sentinel node biopsy. Ann Surg Oncol. 2005; 12: 34-40.
9. Naik AM, Fey J, Gemignani M, et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg. 2004; 240: 462-468; discussion 468-471.
10. Guenther JM, Hansen NM, DiFronzo LA, et al. Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg. 2003; 138: 52-56.
11. Fant JS, Grant MD, Knox SM, et al. Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann Surg Oncol. 2003; 10: 126-130.
12. Sarvi M, Mehta P, Vallow L, et al. Is nodal irradiation necessary in breast cancer patients with positive sentinel node biopsy without axillary dissection [abstract]. Int J Radiat Oncol Biol Phys. 2002; 54: 232-233.
13. Barkley C, Bellon J, Smith B, et al. Can axillary node dissection be omitted in a subset of patients with low local and regional failure [abstract]? Ann Surg Oncol. 2010; 17: S53-S54. Abstract P56.
14. Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010; 252: 426-432; discussion 432-433.
15. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011; 305: 569-575.
16. Reznik J, Cicchetti MG, Degaspe B, et al. Analysis of axillary coverage during tangential radiation therapy to the breast. Int J Radiat Oncol Biol Phys. 2005; 61: 163-168.
17. Cody HS 3rd, Borgen PI,. State-of-the-art approaches to sentinel node biopsy for breast cancer: study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center. Surg Oncol. 1999; 8: 85-91.
18. Cody HS 3rd, Fey J, Akhurst T, et al. Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures. Ann Surg Oncol. 2001; 8: 13-19.
19. Fisher B, Jeong JH, Anderson S, et al. Twenty-5-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002; 347: 567-575.
20. Veronesi U, Viale G, Paganelli G, et al. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg. 2010; 251: 595-600.
21. Kim T, Giuliano AE, Lyman GH,. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a meta-analysis. Cancer. 2006; 106: 4-16.
22. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA. 1996; 276: 1818-1822.
23. Grube BJ, Giuliano AE,. Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial. Semin Surg Oncol. 2001; 20: 230-237.
24. Guenther JM, Krishnamoorthy M, Tan LR,. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am. 1997; 3: 336-340.
25. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancera-a multicenter validation study. N Engl J Med. 1998; 339: 941-946.
26. Veronesi U, Paganelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst. 1999; 91: 368-373.
27. Hill AD, Tran KN, Akhurst T, et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg. 1999; 229: 528-535.
28. Tjan-Heijnen VC, Pepels MJ, de Boer M, et al. Impact of omission of completion axillary lymph node dissection (cALND) or axillary radiotherapy (ax RT) in breast cancer patients with micrometastases (pN1mi) or isolated tumor cells (pN0[i+]) in the sentinel lymph node (SN): results from the MIRROR study [abstract]. J Clin Oncol. 2009; 18S. Abstract CRA506.
29. Schlembach PJ, Buchholz TA, Ross MI, et al. Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation. Int J Radiat Oncol Biol Phys. 2001; 51: 671-678.
30. Alonso-Basanta M, Ko J, Babcock M, et al. Coverage of axillary lymph nodes in supine vs prone breast radiotherapy. Int J Radiat Oncol Biol Phys. 2009; 73: 745-751.
31. Whelan TJ, Olivotto I, Ackerman JW, et al. NCIC-CTG MA. 20: an intergroup trial of regional nodal irradiation in early breast cancer [abstract]. J Clin Oncol. 2011; 29S. Abstract LBA1003.
32. Katz A, Smith BL, Golshan M, et al. Nomogram for the prediction of having 4 or more involved nodes for sentinel lymph node-positive breast cancer. J Clin Oncol. 2008; 26: 2093-2098.
33. Chagpar AB, Scoggins CR, Martin RC 2nd, et al. Predicting patients at low probability of requiring postmastectomy radiation therapy. Ann Surg Oncol. 2007; 14: 670-677.
34. Coen JJ, Taghian AG, Kachnic LA, et al. Risk of lymphedema after regional nodal irradiation with breast conservation therapy. Int J Radiat Oncol Biol Phys. 2003; 55: 1209-1215.
35. Larson D, Weinstein M, Goldberg I, et al. Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys. 1986; 12: 1575-1582.
36. Recht A, Pierce SM, Abner A, et al. Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol. 1991; 9: 988-996.
37. Karam AK, Hsu M, Patil S, et al. Predictors of completion axillary lymph node dissection in patients with positive sentinel lymph nodes. Ann Surg Oncol. 2009; 16: 1952-1958.
38. Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med. 1985; 312: 674-681.
39. Markopoulos C,. Safely promoting breast-conserving surgery and preventing early relapses with an aromatase inhibitor. Surg Oncol. 2008; 17: 113-128.
40. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 365: 1687-1717.